Sentences with phrase «drug companies say»

No matter what drug companies say about their safety, I will never believe that giving drugs creates a better state of health and contributes to longevity.

Why do drug companies say that the older a dog is, the more its immune system is wearing out and therefore, it should be vaccinated more frequently than younger dogs??!!!? To the veterinary college student I say that is exactly the kind of deadly policy that «appalls and disturbs» knowledgeable dog owners!

The FDA, the medical societies and the drug companies say they are all mystified as to Why this is happening with this extremely important class of drugs.

Drug companies say the law will not only be ineffective, but will also threaten innovation and development.

Not exact matches

May 1 - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.

But when they broached the idea of developing such a vaccine with drug companies, nearly all of them said, «No, thank you very much, but we're not interested,» recalls Schiller in a Lasker Foundation interview.

«When you put these two things together, you've got a novel new drug,» says Steve Gilman, the company's chief scientific officer.

The $ 1.1 billion Alphabet - backed Silicon Valley unicorn 23andMe just pulled off a milestone feat: On Thursday, the Food and Drug Administration (FDA) said the company could sell its genetic tests and accompanying health risk reports for ten different diseases directly to consumers.

The Boston company is seeking FDA approval for an under - the - skin pump system that it says can dispense a steady stream of diabetes drugs for a period of six months or longer.

Sysco says he suspected the technology would need to gain FDA approval from the time the company launched in 2005, because it was designing an app that physicians would prescribe like a drug or device.

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

The Food and Drug Administration delivered a boon to U.S. drug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual salDrug Administration delivered a boon to U.S. drug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual saldrug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual saldrug that analysts say could wring in billions of dollars in annual sales).

Matt de Silva, CEO of drug testing firm Notable Labs, said he co-founded the company after his father was diagnosed with multiple glioblastomas and was excluded from many trials because of the nature of his condition.

Miller, chief investment officer at LMM, said he thinks the embattled drugmaker is «a completely different company» than the one that was under severe fire for jacking up drug prices, and could see returns of 25 percent to 30 percent per year over the next five years.

MONTREAL — Valeant Pharmaceuticals faces years of legal challenges despite cutting ties with a U.S. mail - order pharmacy at the centre of a controversy about how Canada's largest publicly traded drug firm conducts its business, say industry observers and the company's second - largest shareholder.

Capping off 2017, the company say its stock jump 3.9 % when Metro Inc. began selling back the majority of its Couche - Tard shares — about $ 1.55 billion worth — to help fund its purchase of sister drug store chain Jean Coutu Group Inc..

Weston said his family, who also controls Loblaw's parent company, George Weston Ltd. (TSX: WN), has undergone some major changes in the past year, including the $ 12.4 - billion blockbuster acquisition of the Shoppers Drug Mart chain.

Valeant (TSX: VRX) said it had lost confidence in the Hatboro, Pa., - based company and was exploring relationships with other pharmacies to fill prescriptions for its drugs.

«Far and away the biggest value - creating step that a company can have is evolving from concept to drug,» says Brian Bapty, a biotechnology analyst with Vancouver - based brokerage Raymond James Financial Inc. «It's one of the best businesses to be in, albeit one of the higher - risk businesses.»

Says Bapty: «If a CRO is nimble and can evolve technology that can enable its clients to get a drug approved faster or to reduce the risk of a clinical study, or even save them development money in the long run, that company will find it has a long - term business plan.»

The company, which has been selling non-core assets, said it had divested the North American rights to the hereditary angioedema drug, Ruconest, to Netherlands - based Pharming Group NV in deal worth up to $ 165 million.

Activist hedge fund investor and recent Valeant Pharmaceuticals (vrx) board appointee Bill Ackman on Wednesday slammed the company's steep drug price hikes in testimony before the U.S. Senate Special Committee on Aging, going so far as to say the cost bumps «contributed to healthcare inflation and called into question the company's commitment to the patients it serves.»

The Food and Drug Administration said late Thursday it will not require preliminary review before companies can sell so - called carrier screening tests to the public.

«When it comes to making iPhones, it is detrimental to your company to drug test employees,» Williams says, half in jest.

KIND bars faced some problematic press in 2015 as well, when a warning letter from the U.S. Food and Drug Administration said several of the company's products weren't as healthy as advertised.

Brendan Kennedy, the cofounder of Privateer Holdings, which owns various marijuana companies like Marley Natural and Canadian pharmaceutical - grade cannabis producer Tilray, says his companies are expanding abroad while the U.S. Drug Enforcement Agency and the Food and Drug Administration debate whether or not to treat the plant as a medicine or keep it in the same category as heroin.

The company is selling a thing (the kit) by saying it can provide «health reports on 254 diseases and conditions,» including categories such as «carrier status,» «health risks,» and «drug response,» and specifically as a «first step in prevention» that enables users to «take steps toward mitigating serious diseases» such as diabetes, coronary heart disease, and breast cancer...» Most of the uses «listed on your website, a list that has grown over time,» the FDA writes, «are medical device uses [for the] Personal Genome Service.»

Merck is the latest company to weather bad news in the Alzheimer's drug race, halting a late - stage trial yesterday in an experimental amyloid - targeting candidate called verubecestat after a data monitoring committee said there was «virtually no chance of finding a positive clinical effect,» Reuters reported.

«We have an agreement with them where we own the drug, but anything that's funded by the U.S. government, it reserves the right to use that under certain circumstances,» says Mark Murray, president and CEO of the Burnaby, B.C., company.

«Shoppers tends to be a Top Five company, but last year was a low point for them with the fight for generic drugs,» says Susan Quinn - Mullins, a senior adviser to the Research Institute.

The company has responded with statements saying that it's not as dependent on drug price increases as critics have claimed; it has also pointed out that while attention has focused on changes in list prices for drugs, those prices don't reflect the actual cost for insurers, governments and other group purchasers, which typically receive discounts that aren't publicly disclosed.

If employers are looking for ways to reduce costs for things like absenteeism, prescription drug benefits or long - term disabilities, Lowe says they must take a clear - eyed look at the company's role in, well, making people sick in the first place.

Canadian company Shoppers Drug Mart lets employees take days off if they have a loss in the family, and they say that includes a beloved pet.

Walgreens is now said to be in early - stage talks to acquire drug wholesale company AmerisourceBergen, The Wall Street Journal has reported.

LONDON / NEW YORK / TOKYO, April 25 - Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $ 64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company since 2000..

Both companies have since rolled back their price increases, and experts say that while drug prices will continue to rise the practice of hiking prices purely for profit may be on the wane.

PARIS, April 17 - French healthcare group Sanofi is in exclusive talks to sell its Zentiva European generics drugs arm to private equity firm Advent International for 1.9 billion euros, the companies said on Tuesday.

Given its areas of specialization, Gilead wouldn't benefit as much from consolidation as, say, a generic - drug company would, but it still faces pricing pressure: To appease Medicaid and other insurers, Gilead is already steeply discounting its hep - C drugs, which can cost more than $ 80,000 for a 12 - week course.

The company recently said it is going to pay $ 465 million to the Department of Justice and other government agencies over the way it classified the EpiPen in the Medicaid Drug Rebate Program.

The company couldn't say whether its drug price increases have typically occurred before or after a generic version launches, but said that once a generic is available, it would expect to lose so much market share that it «needs to increase the price to keep production of the drug viable.»

The Danish company said it would pay 28.00 euros per share in cash for Ablynx and an additional 2.50 euros in a so - called contingent value right (CVR) if certain conditions related to other drugs in Ablynx's research portfolio were met.

Potential Trump victory beneficiaries, Golub said, included drug companies.

«The companies deliberately exploited the opportunity offered by debranding to hike up the price for a drug which is relied upon by many thousands of patients,» Philip Marsden, chairman of the CMA's case decision group, said on Wednesday.

Clinton has said she plans to combat high drug prices, which could be a drag for pharmaceutical companies.

«It's hard to know what incentives will work for the pharmaceutical companies to increase drug production,» said the University of Utah's Fox.

Fox Chase Cancer Center's Kloth said if there was a way that drug companies could be assured their investment would be recouped, that would help ease the shortage.

Sharei says he is actively discussing partnerships with more drug companies to develop more ways to engineer cells to fight disease, but he declined to identify which drug companies or which diseases.

Sykes says it's much better if a company has 20 drugs, each accounting for 5 % of revenues.

Some of the smaller companies developing immunotherapy drugs could be acquired by the pharmaceutical giants, analysts said.

Ackman is joining Valeant's board and has said he is taking a more active role in trying to turn around the troubled drug company.